192 related articles for article (PubMed ID: 34237460)
21. Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics.
Zhou H; Li Q; Wang T; Liang H; Wang Y; Duan Y; Song M; Wang Y; Jin H
Medicine (Baltimore); 2019 Jun; 98(26):e16192. PubMed ID: 31261558
[TBL] [Abstract][Full Text] [Related]
22. Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples - a Pilot Study.
Burian A; Lujber L; Gerlinger I; Jarai T; Orosz E; Turiak L; Acs A; Hegedus Z; Peter AK; Tornoczki T; Gombos K; Mark L
Pathol Oncol Res; 2020 Oct; 26(4):2801-2807. PubMed ID: 32564264
[TBL] [Abstract][Full Text] [Related]
23. Identification of proteins associated with development of metastasis from cutaneous squamous cell carcinomas (cSCCs) via proteomic analysis of primary cSCCs.
Shapanis A; Lai C; Smith S; Coltart G; Sommerlad M; Schofield J; Parkinson E; Skipp P; Healy E
Br J Dermatol; 2021 Apr; 184(4):709-721. PubMed ID: 32794257
[TBL] [Abstract][Full Text] [Related]
24. Exploring the "gene-protein-metabolite" network of coronary heart disease with phlegm and blood stasis syndrome by integrated multi-omics strategy.
Yang G; Zhou S; He H; Shen Z; Liu Y; Hu J; Wang J
Front Pharmacol; 2022; 13():1022627. PubMed ID: 36523490
[No Abstract] [Full Text] [Related]
25. Long non-coding RNA PICSAR serves as a non-invasive biomarker for the diagnosis and prognosis of cutaneous squamous cell carcinoma.
Lv J; Zhang W; Wang Y
Clin Exp Med; 2021 Nov; 21(4):579-586. PubMed ID: 34043139
[TBL] [Abstract][Full Text] [Related]
26. Metabolomics and proteomics technologies to explore the herbal preparation affecting metabolic disorders using high resolution mass spectrometry.
Zhang A; Zhou X; Zhao H; Zou S; Ma CW; Liu Q; Sun H; Liu L; Wang X
Mol Biosyst; 2017 Jan; 13(2):320-329. PubMed ID: 28045158
[TBL] [Abstract][Full Text] [Related]
27. 4D DIA-PRM proteomic study identifying modulated pathways and biomarkers associated with pelvic organ prolapse.
Deng W; Zhong Z; Tong Y; Liu J; Wang X; Xu L; Li Y; Chen X; Wei Q; Rao J
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov; 1230():123916. PubMed ID: 37922782
[TBL] [Abstract][Full Text] [Related]
28. Integration of quantitative proteomics and metabolomics reveals tissue hypoxia mechanisms in an ischemic-hypoxic rat model.
He R; Kong Y; Fang P; Li L; Shi H; Liu Z
J Proteomics; 2020 Sep; 228():103924. PubMed ID: 32736140
[TBL] [Abstract][Full Text] [Related]
29. Association of proteome and metabolome signatures with severity in patients with community-acquired pneumonia.
Gesell Salazar M; Neugebauer S; Kacprowski T; Michalik S; Ahnert P; Creutz P; Rosolowski M; ; Löffler M; Bauer M; Suttorp N; Kiehntopf M; Völker U
J Proteomics; 2020 Mar; 214():103627. PubMed ID: 31899367
[TBL] [Abstract][Full Text] [Related]
30. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
31. The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated HK2 and mTOR Signals.
Zhu Y; Liu M; Yao J; Guo Q; Wei L
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143000
[TBL] [Abstract][Full Text] [Related]
32. The Expression Status and Prognostic Value of Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma.
Xu R; Cai MY; Luo RZ; Tian X; Han JD; Chen MK
JAMA Dermatol; 2016 Mar; 152(3):305-11. PubMed ID: 26560495
[TBL] [Abstract][Full Text] [Related]
33. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
35. Studies on Novel Diagnostic and Predictive Biomarkers of Intrahepatic Cholestasis of Pregnancy Through Metabolomics and Proteomics.
Dong R; Ye N; Zhao S; Wang G; Zhang Y; Wang T; Zou P; Wang J; Yao T; Chen M; Zhou C; Zhang T; Luo L
Front Immunol; 2021; 12():733225. PubMed ID: 34721396
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
37. Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma.
Wang H; Li H; Yan Q; Gao S; Gao J; Wang Z; Sun Y
BMC Cancer; 2021 Jul; 21(1):816. PubMed ID: 34266392
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of proteomic and metabolomic profiles of different species of Paris.
Liu F; Meng Y; He K; Song F; Cheng J; Wang H; Huang Z; Luo Z; Yan X
J Proteomics; 2019 May; 200():11-27. PubMed ID: 30890455
[TBL] [Abstract][Full Text] [Related]
39. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
[TBL] [Abstract][Full Text] [Related]
40. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
